Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT05409209

Carotid Plaque Length to Predict Cardiovascular Events

This multicenter study involved 5 hospitals (Changhai Hospital; Yueyang Hospital of Shanghai University of Traditional Chinese Medicine; Gongli Hospital; Putuo Hospital of Shanghai University of Traditional Chinese Medicine; No. 904 Hospital of the PLA Joint Logistics Support Force Wuxi). The study enrolled 3000 patients for suspected CAD who referred to coronary angiography from January 2017 through December 2018.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Conditions

Coronary Artery Disease Arterial Occlusive Diseases Arteriosclerosis Cardiovascular Diseases Coronary Disease Heart Diseases Myocardial Ischemia Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

No. 904 Hospital of the PLA Joint Logistics Support Force, Wuxi, Jiangsu, China

Loading trial locations.

About this study

Patients with coronary artery disease who were confirmed by coronary angiography were eligible for the study. Carotid ultrasonography was performed before coronary angiography, and carotid intima-media thickness (IMT), maximum thickness and length of all plaques were measured.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients≥18 years old, those who underwent carotid ultrasonography and first coronary angiography simultaneously.

Exclusion criteria

  • Patients with known coronary artery disease, previous coronary or carotid revascularization, missing carotid ultrasound or coronary angiography results.

Treatment and study plan

Primary outcomes

  1. major cardiovascular event

    Time frame: 3 years

    A composite of cardiovascular death, myocardial infarction, and ischemic stroke

Secondary outcomes

  1. major vascular event

    Time frame: 3 years

    A composite of cardiovascular death, myocardial infarction, ischemic stroke, and coronary artery revascularization

  2. all-cause death

    Time frame: 3 years

  3. cardiovascular death

    Time frame: 3 years

  4. myocardial infarction

    Time frame: 3 years

  5. ischemic stroke

    Time frame: 3 years

  6. coronary artery revascularization

    Time frame: 3 years

    coronary artery bypass grafting or percutaneous coronary intervention

Sponsors and collaborators

Lead sponsor

Changhai Hospital

Other

Collaborators

  • 904th Hospital of the Joint Logistics Support Force of the PLA
  • Gongli Hospital
  • Putuo Hospital, Shanghai University of Traditional Chinese Medicine
  • Yueyang Hospital, Shanghai University of Traditional Chinese medicine

Registry information

Important dates

Study start
2017
Primary completion
2021
Study completion
2030
First posted
Jun 8, 2022
Registry last updated
Sep 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.